![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/167 | (2006.01) |
A61K 45/06 | (2006.01) | ||
A61P 3/06 | (2006.01) | ||
A61K 31/225 | (2006.01) | ||
A61K 31/325 | (2006.01) | ||
A61K 31/366 | (2006.01) | ||
A61K 31/40 | (2006.01) | ||
A61K 31/401 | (2006.01) |
(11) | Number of the document | 2289502 |
(13) | Kind of document | T |
(96) | European patent application number | 10011299.4 |
Date of filing the European patent application | 2004-04-30 | |
(97) | Date of publication of the European application | 2011-03-02 |
(45) | Date of publication and mention of the grant of the patent | 2015-07-22 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
467418 P | 2003-05-02 | US | |
471495 P | 2003-05-16 | US | |
477372 P | 2003-06-10 | US | |
534856 P | 2004-01-08 | US |
(72) |
Urata, Yasuo, JP
Hoshino, Shoji, JP
Kawamura, Hitoshi, JP
Okamoto, Hiroshi, JP
Furukawa, Noboru, JP
|
(73) |
Japan Tobacco Inc.,
2-1, Toranomon 2-chome, Minato-ku, Tokyo 105-8422,
JP
|
(54) | Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an hmg coa reductase inhibitor |
Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an hmg coa reductase inhibitor |